NEW YORK (GenomeWeb) – Interpace Diagnostics announced today that Aetna has agreed to cover its ThyraMir microRNA classifier test for thyroid nodules.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.